C12Y 201/01062
Mrna -methyltransferase
Official title: mRNA (2'-O-methyladenosine-N6-)-methyltransferase (2.1.1.62)
C12Y201/01062 (Mrna -methyltransferase) appears on 2 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 7
- Assignees
- 6
- Inventors
- 15
- Latest grant
- 2 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- M6a mrna modification in cancer treatment13 Mar 2025US 2025/0082733 A1City of Hope
- Targeting xist and rna methylation for x reactivation therapy30 Nov 2023US 2023/0383292 A1The General Hospital Corporation
- Targeting rna viruses using inhibitors of mettl328 Apr 2022US 2022/0125768 A1New York University
- Cell line with METTL3 gene knocked out, its construction method and interference vector13 Jan 2022US 2022/0010272 A1Zhejiang University
- Modified oligonucleotides and methods of use21 Jan 2021US 2021/0015884 A1Janssen BioPharma, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.